AU4441899A - Process for preparing pharmaceutical bulk material having uniform dissolution - Google Patents
Process for preparing pharmaceutical bulk material having uniform dissolutionInfo
- Publication number
- AU4441899A AU4441899A AU44418/99A AU4441899A AU4441899A AU 4441899 A AU4441899 A AU 4441899A AU 44418/99 A AU44418/99 A AU 44418/99A AU 4441899 A AU4441899 A AU 4441899A AU 4441899 A AU4441899 A AU 4441899A
- Authority
- AU
- Australia
- Prior art keywords
- bulk material
- preparing pharmaceutical
- uniform dissolution
- pharmaceutical bulk
- dissolution
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
- A61K9/1688—Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
- A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13421599P | 1999-05-14 | 1999-05-14 | |
US60134215 | 1999-05-14 | ||
PCT/US1999/013481 WO2000069417A1 (en) | 1999-05-14 | 1999-06-15 | Process for preparing pharmaceutical bulk material having uniform dissolution |
Publications (1)
Publication Number | Publication Date |
---|---|
AU4441899A true AU4441899A (en) | 2000-12-05 |
Family
ID=22462288
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU44418/99A Abandoned AU4441899A (en) | 1999-05-14 | 1999-06-15 | Process for preparing pharmaceutical bulk material having uniform dissolution |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP1180022A4 (en) |
AU (1) | AU4441899A (en) |
WO (1) | WO2000069417A1 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6465615B1 (en) * | 2001-09-10 | 2002-10-15 | Astrazeneca Ab | Monohydrate lisinopril |
US6468976B1 (en) * | 2001-09-10 | 2002-10-22 | Astrazeneca Ab | Monohydrate lisinopril |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS601128A (en) * | 1983-06-15 | 1985-01-07 | Shionogi & Co Ltd | Long-acting cefaclor preparation |
US5026560A (en) * | 1987-01-29 | 1991-06-25 | Takeda Chemical Industries, Ltd. | Spherical granules having core and their production |
US4968508A (en) * | 1987-02-27 | 1990-11-06 | Eli Lilly And Company | Sustained release matrix |
IT1251999B (en) * | 1991-11-11 | 1995-05-27 | Opos Biochimica Srl | CRYSTALLINE SHAPE OF A CEPHALOSPORIN ANTIBIOTIC |
US5837292A (en) * | 1996-07-03 | 1998-11-17 | Yamanouchi Europe B.V. | Granulate for the preparation of fast-disintegrating and fast-dissolving compositions containing a high amount of drug |
-
1999
- 1999-06-15 WO PCT/US1999/013481 patent/WO2000069417A1/en not_active Application Discontinuation
- 1999-06-15 AU AU44418/99A patent/AU4441899A/en not_active Abandoned
- 1999-06-15 EP EP99927538A patent/EP1180022A4/en not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
EP1180022A4 (en) | 2004-01-07 |
WO2000069417A1 (en) | 2000-11-23 |
EP1180022A1 (en) | 2002-02-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUP0203198A3 (en) | Pharmaceutical composition comprising a tramadol material and an anticonvulsant drug, process for its preparation and its use | |
HK1043087A1 (en) | Soluble material and process for three-dimensionalmodeling | |
HUP0201376A2 (en) | Thiazoloderivatives and pharmaceutical compositions containing them and process for preparation the compounds | |
HUP0100431A3 (en) | Adamantana derivatives, pharmaceutical compositions comprising them and process for preparing them | |
HUP0000748A3 (en) | 4-phenyl-piridine derivatives, process for producing them and pharmaceutical compositions containing them | |
HUP0200076A3 (en) | C-21 modified epothilones, process for their preparation, pharmaceutical compositions containing them | |
AU143343S (en) | A container for example for a pharmaceutical substance | |
AU7123700A (en) | Process for preparing polyolefin products | |
AU5491000A (en) | Process and apparatus for preparing a composition using a slurry feed | |
HUP0201516A2 (en) | 13-methyl-erythromycin derivatives, process for their preparation and pharmaceutical compositions containing them | |
HUP0201753A2 (en) | Pyridopyranoazepine derivatives, process for their preparation and pharmaceutical compositions containing them | |
HUP0201402A3 (en) | Bis-sulfonamides, process for their preparation and pharmaceutical compositions containing them | |
EG22337A (en) | Process for preparing novel pharmaceutical compounds | |
HUP0202731A3 (en) | O-anisamide derivatives, process for their preparation and pharmaceutical compositions containing them | |
HUP9801950A3 (en) | 2-(arylphenyl-amino)-imidazoline derivatives, process for producing them and pharmaceutical compositions containing them | |
HUP0105479A3 (en) | Betha-alanine derivatives, process for producing them and pharmaceutical compositions containing them | |
IL131205A0 (en) | Process for preparing pharmaceutical compounds | |
HUP0201916A2 (en) | Ethanesulfonyl-piperidine derivatives, process for producing them and pharmaceutical compositions containing them | |
AU4441899A (en) | Process for preparing pharmaceutical bulk material having uniform dissolution | |
HUP0200003A3 (en) | Tetrahydrothiopyran-o-fluorinated phenylcarbamate derivatives and process for their preparation | |
AU2471501A (en) | Method and system for introducing a new material into a product design system | |
HUP0200376A3 (en) | Thiaoloindolinone compounds, process for their preparation and pharmaceutical composions containing them and their use | |
HUP9902559D0 (en) | Pharmaceutical composition and process for producing it | |
AU2672301A (en) | Process for the biotechnological preparation of l-erythrulose | |
HUP0004543A3 (en) | Aminopyrroline compounds, process for their preparation and pharmaceutical compositions containing them |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |